Mycobacterium avium subspecies Paratuberculosis and Crohn's regional ileitis: how strong is association?

Sarman Singh1, Krishnamoorthy Gopinath

  • 1Department of Laboratory Medicine, Division of Clinical Microbiology, All India Institute of Medical Sciences, New Delhi, India. sarman_singh@yahoo.com

Insights

Mycobacterium avium subsp. paratuberculosis (MAP) is linked to Crohn's disease (CD) in humans. This review explores the evidence for MAP as a cause of CD, considering genetic and environmental factors, and highlights research inconsistencies.

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • Mycobacterium avium subsp. paratuberculosis (MAP) is a known cause of Johne's disease in animals.
  • MAP has been investigated as a potential etiological agent for Crohn's disease (CD) in humans.
  • The role of MAP in CD pathogenesis remains debated, with theories suggesting it as a cause or an immune-inflammatory trigger.

Purpose of the Study:

  • To review the current evidence and conflicting findings regarding MAP's role in human Crohn's disease.
  • To present a perspective on the etiological debate surrounding MAP and CD.
  • To stimulate further discussion and research into the potential link between MAP and CD.

Main Methods:

  • Literature review of studies investigating MAP and Crohn's disease.
  • Analysis of factors contributing to CD onset, including genetics, environment, and immune response.
  • Discussion of methodological variations and quality control issues in relevant research.

Main Results:

  • Contradictory findings exist in the literature regarding MAP's association with CD.
  • CD onset is multifactorial, involving genetic predisposition, environmental stimuli, and immune responses.
  • Inconsistencies in study designs, specimen selection, and laboratory quality control complicate definitive conclusions.

Conclusions:

  • The etiological role of MAP in human Crohn's disease is not definitively established.
  • A combination of genetic, environmental, and immune factors likely contributes to CD development.
  • Further standardized research is needed to resolve the debate on MAP as a causative agent of CD.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...